It is possible to observe characteristic dynamics of reducing of margin during the period from 2009 to 2016. If it constituted from 15% to 10% till 2015, then since 2016 it constituted 8.5%. The margin in the amount of 8% is approved by the solution of the Supervisory board of SK-Pharmation LLP in 2016.

Effective use of budgetary funds is one of strategically important directions of the Single distributor. Reduction of the size of a margin of SK-Pharmation LLP will allow to cut down expenses of the medical organizations on purchase of medicines and products of medical appointment and to reduce burden from the government budget.

Besides, this obligation of fulfillment on forming of minimum inventory of medicines for treatment of socially important diseases (AIDS, oncology, tuberculosis).+

Let's remind, the Single distributor at the expense of own means created minimum inventory of medicines. The created minimum inventory will be the support for the medical organizations on a case of the emergency need of additional medicines and uninterruptedness of providing.